Detalhe da pesquisa
1.
Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma.
Cell
; 150(6): 1135-46, 2012 Sep 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-22980977
2.
Whole-genome landscapes of major melanoma subtypes.
Nature
; 545(7653): 175-180, 2017 05 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28467829
3.
Phylogenetic analyses of melanoma reveal complex patterns of metastatic dissemination.
Proc Natl Acad Sci U S A
; 112(35): 10995-1000, 2015 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26286987
4.
Negative immune checkpoint regulation by VISTA: a mechanism of acquired resistance to anti-PD-1 therapy in metastatic melanoma patients.
Mod Pathol
; 30(12): 1666-1676, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28776578
5.
BRAF(V600E) and NRAS(Q61L/Q61R) mutation analysis in metastatic melanoma using immunohistochemistry: a study of 754 cases highlighting potential pitfalls and guidelines for interpretation and reporting.
Histopathology
; 69(4): 680-6, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27151331
6.
Tumor PD-L1 expression, immune cell correlates and PD-1+ lymphocytes in sentinel lymph node melanoma metastases.
Mod Pathol
; 28(12): 1535-44, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26403784
7.
Expression of the class 1 histone deacetylases HDAC8 and 3 are associated with improved survival of patients with metastatic melanoma.
Mod Pathol
; 28(7): 884-94, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25836739
8.
Genetic and clinico-pathologic analysis of metastatic uveal melanoma.
Mod Pathol
; 27(2): 175-83, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23887304
9.
Dynamic Changes in PD-L1 Expression and Immune Infiltrates Early During Treatment Predict Response to PD-1 Blockade in Melanoma.
Clin Cancer Res
; 23(17): 5024-5033, 2017 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28512174
10.
PD-L1 Expression and Immune Escape in Melanoma Resistance to MAPK Inhibitors.
Clin Cancer Res
; 23(20): 6054-6061, 2017 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28724663
11.
Targeted therapies and immune checkpoint inhibitors in the treatment of metastatic melanoma patients: a guide and update for pathologists.
Pathology
; 48(2): 194-202, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27020392
12.
Comparison of whole-exome sequencing of matched fresh and formalin fixed paraffin embedded melanoma tumours: implications for clinical decision making.
Pathology
; 48(3): 261-6, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-27020503
13.
PD-L1 expression in melanoma shows marked heterogeneity within and between patients: implications for anti-PD-1/PD-L1 clinical trials.
Pigment Cell Melanoma Res
; 28(3): 245-53, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25477049
14.
PD-L1 Expression and Tumor-Infiltrating Lymphocytes Define Different Subsets of MAPK Inhibitor-Treated Melanoma Patients.
Clin Cancer Res
; 21(14): 3140-8, 2015 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25609064
15.
Tumour procurement, DNA extraction, coverage analysis and optimisation of mutation-detection algorithms for human melanoma genomes.
Pathology
; 47(7): 683-93, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26517638
16.
Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathway.
Nat Genet
; 47(10): 1194-9, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26343386
17.
How anti-PD1 treatments are changing the management of melanoma.
Melanoma Manag
; 1(2): 165-172, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-30190821
18.
Concordant BRAFV600E mutation status in primary melanomas and associated naevi: implications for mutation testing of primary melanomas.
Pathology
; 46(3): 193-8, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24614711
19.
Identification of new prognostic biomarkers for Stage III metastatic melanoma patients.
Oncoimmunology
; 2(9): e25564, 2013 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24228228
20.
BRAF/NRAS wild-type melanomas have a high mutation load correlating with histologic and molecular signatures of UV damage.
Clin Cancer Res
; 19(17): 4589-98, 2013 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23833303